Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Sep 15:4:332-333.
doi: 10.1016/j.xjtc.2020.09.003. eCollection 2020 Dec.

Commentary: Opening a window when surgeons face awesome responses to immunotherapy

Stephan Adamour Soder  1 , Moishe Liberman  1
Affiliations
Editorial

Commentary: Opening a window when surgeons face awesome responses to immunotherapy

Stephan Adamour Soder et al. JTCVS Tech. .
No abstract available

PubMed Disclaimer

Figures

None
Omentum used as a pedicled flap to cover a large anterior chest wall defect after resection in a patient who underwent induction immunotherapy.
See this image and copyright information in PMC

Comment on

References

    1. Migden M.R., Rischin D., Schmults C.D., Guminski A., Hauschild A., Lewis K.D., et al. PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma. N Engl J Med. 2018;379:341–351. - PubMed
    1. Migden M.R., Khushalani N.I., Chang A.L.S., Lewis K.D., Schmults C.D., Hernandez-Aya L., et al. Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial. Lancet Oncol. 2020;21:294–305. - PMC - PubMed
    1. Choi J.J., Allen R.J., Bains M.S., Cohen M.A., Yu Y., Elmadhun N., et al. Complex chest wall surgery to prevent vascular complications after immunotherapy and radiation treatment. J Thorac Cardiovasc Surg Tech. 2020;4:329–331. - PMC - PubMed
    1. Cabel L., Proudhon C., Romano E., Girard N., Lantz O., Stern M.H., et al. Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy. Nat Rev Clin Oncol. 2018;15:639–650. - PubMed
    1. Weiss G.J., Beck J., Braun D.P., Bornemann-Kolatzki K., Barilla H., Cubello R., et al. Tumor cell-free DNA copy number instability predicts therapeutic response to immunotherapy. Clin Cancer Res. 2017;23:5074–5081. - PubMed

LinkOut - more resources